Table 2: Clinical characteristics of HIV positive patients on first line ART in UOG, North West Ethiopia from Jan 1, 2012 to Dec 31, 2017.
| Variable | Category | Frequency | Percent |
| Adherence | Good | 249 | 79 |
| Not good | 66 | 21 | |
| Base line BMI | > 18.5 kg/m2 | 261 | 82.9 |
| ≤ 18.5 kg/m2 | 54 | 17.1 | |
| Base line WHO Stage | Early stage (stage 1 and 2) | 158 | 50.2 |
| Advanced stage (stage 3 and 4) | 157 | 49.8 | |
| Base line CD4 | ≥ 100 cell/mm3 | 244 | 77.5 |
| < 100 cell/mm3 | 71 | 22.5 | |
| Type of ART failure | Virologic failure | 6 | 1.9 |
| Immunologic failure | 6 | 1.9 | |
| Virologic and Immunologic failure | 11 | 3.5 | |
| All types of failure | 9 | 2.9 | |
| TB Co-infection | Yes | 47 | 14.9 |
| No | 268 | 85.1 | |
| Presence of OIS | Yes | 72 | 22.9 |
| No | 268 | 85.1 | |
| Type of ART regimen | AZT/3TC/EFV or TDF/3TC/EFV | 216 | 68.6 |
| AZT/3TC/NVP or TDF/3TC/NVP | 99 | 31.4 | |
| Functional status | Working | 272 | 86.3 |
| Ambulating | 35 | 11.1 | |
| Bedridden | 8 | 2.6 | |
| ART drug toxicity | Yes | 67 | 21.3 |
| No | 248 | 78.7 | |
| Viral load determination time | vAt 6 months of ART | 27 | 8.6 |
| After 6 months of ART | 288 | 91.4 |